Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

A Study on the Safety and Effectiveness of the Mantra™ Surgical Robotic System for Soft Tissue Surgeries

NCT06974955 · Sudhir Srivastava Innovations Pvt. Ltd. · Updated 16 May 2025

What is being tested
Not stated
For
Soft Tissue Surgeries
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages Not stated. About 365 people. The full rules are on the registry page.
Where
India
When
Starts or started May 2025, ends Nov 2025. Registered 16 May 2025.
Results
None posted yet.

In the researchers' words

A Real-World, multicentre retrospective study to evaluate the clinical performance and safety of MantraTM Surgical Robotic System for soft tissue surgeries. The purpose of this retrospective study is to evaluate the clinical performance and safety of the Mantra™ Surgical Robotic System, Model 3.0, for soft tissue surgeries. It aims to provide real-world evidence on the system's reliability, safety, and effectiveness in the real world population. The SSI Mantra 3.0 Surgical Robotic System is an advanced, modular, and cost-effective robotic-assisted surgical platform designed to enhance precision, flexibility, and control in minimally invasive surgeries (MIS). The objective of this retrospective study is to assess the clinical performance and safety of the Mantra™ Surgical Robotic System in performing various soft tissue surgeries based on retrospective data analysis.
ClinicalTrials.gov, NCT06974955

Sites

  • ASTER CMI HospitalBangalore, Karnataka, India